TDRL-X80

Electrophoretic mobility shift assay detects protein-nucleic acid binding by incubating a labeled DNA or RNA probe with purified protein or cell extract, then separating free probe from slower-migrating protein-probe complexes on a native gel. For cancer cells, primary neurons, mouse tumor samples, intestinal organoids, inflammatory macrophages, or drug-treated samples, EMSA can measure transcription-factor DNA binding or RNA-binding protein activity in extracts, but it does not directly measure transcription, protein expression, or chromatin occupancy in intact cells. Specificity is judged by competition with unlabeled wild-type probe, failure of mutated or unrelated competitors to compete, and antibody supershift or disruption when the binding protein identity must be confirmed.

Enzyme-linked immunosorbent assay (ELISA) is a biochemical technology widely used to detect and quantify proteins, antibodies, hormones and other biomolecules. This method uses enzyme-labeled antibodies or antigens to specifically bind to the test substance, and generates a measurable signal through an enzyme-catalyzed reaction. ELISA has the characteristics of high sensitivity, specificity and high-throughput, and is suitable for medical diagnosis, biomedical research and drug development and other fields.